Related Experiment Video
Updated: Jul 3, 2026
06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Gastrointestinal stromal tumours: CT findings
S Ulusan1, Z Koc, F Kayaselcuk
1Department of Radiology, Baskent University Faculty of Medicine, Adana Teaching and Medical Research Center, Dadaloglu Mah, 39 Sok No 6, 01250, Yuregir, Adana, Turkey. sulusan@hotmail.com
The British Journal of Radiology
|July 17, 2008
Summary
Computed Tomography (CT) can identify malignant behavior predictors in gastrointestinal stromal tumors (GISTs). Key indicators include tumor size, location, enhancement patterns, and metastatic spread, aiding in early diagnosis.
Area of Science:
- Radiology
- Oncology
- Gastroenterology
Background:
- Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors of the gastrointestinal tract.
- Predicting the malignant potential of GISTs is crucial for patient management.
Purpose of the Study:
- To identify predictors of malignancy in GISTs using Computed Tomography (CT).
- To illustrate uncommon radiological features of GISTs on CT scans.
Main Methods:
- Retrospective analysis of CT findings in 30 patients diagnosed with GIST.
- Statistical comparison (chi-squared or Fisher's exact tests) of CT features with mitotic index.
- Evaluation of relationships between mitotic index and tumor characteristics (location, size, enhancement, metastasis, etc.).
Main Results:
- Tumor size, localization, enhancement pattern, liver/distant metastasis, and cystic-necrotic components were significantly associated with a high mitotic index (p<0.05).
- Uncommon CT findings included saccular aneurysmal dilatation, malignant lymphadenopathy, and satellite nodules.
- CT features effectively identified predictors of malignant behavior in GISTs.
Conclusions:
- CT imaging plays a vital role in assessing the malignant potential of GISTs.
- Specific CT findings can predict aggressive behavior and guide treatment decisions for GIST patients.
